Gateway 2012: Brabender Pharma - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Brabender Pharma


Brabender® Pharma USA, Inc.
50 East Wesley Street
South Hackensack, NJ 07606
Kevin Van Allen
201.220.6660
cwbi@cwbrabender.com
www.brabender-pharma.com

Be sure to visit us at AAPS 2012, booth # 4900

Brabender® Pharma USA, Inc. is an innovative company specializing in the manufacturing of twin-screw extruders for HME applications. The effort has been to concentrate on top quality equipment to produce small batch sizes up to production scale processes. The 12 mm Mini-Compounder is ideally suited to this undertaking while other models offer options to achieve production capacity. Our success is accomplished by many years of knowledge in this area – we present a solution to the increased demand for small batch analysis while providing the finest quality equipment and instruments. Brabender® Pharma is pleased to announce the opening of our new GMP Pharma Testing Laboratory located in Duisburg, Germany. With the introduction of this laboratory, we complement our customers’ needs for a GMP testing laboratory utilizing our 12 mm Mini-Compounder for HME – Hot Melt Extrusion.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here